Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 0904-6291

6 FDA label images from Major Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 0904-6291). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical-structure (Chemical Structure)

Chemical-structure (Chemical Structure)
Chemical structure of atorvastatin calcium, shown as two calcium ions (Ca2+) complexed with the atorvastatin molecule and its associated chemical groups.*
FDA Label Image

Figure-01 (Figure 01)

Figure-01 (Figure 01)
A line chart showing cumulative incidence (%) over time (years) comparing Atorvastatin versus placebo. The graph features two lines, one solid representing Atorvastatin and one dashed representing placebo, with Atorvastatin showing lower cumulative incidence. The chart includes a hazard ratio (HR=0.64) with confidence interval and p-value indicating statistical significance.*
FDA Label Image

Figure-02 (Figure 02)

Figure-02 (Figure 02)
A line graph depicting cumulative hazard percentage over time in years, comparing placebo and atorvastatin groups through four years of follow-up. The placebo group is represented by a dashed line showing a higher cumulative hazard compared to the solid line for atorvastatin. The graph includes a hazard ratio (HR) of 0.63 with a confidence interval and a p-value of 0.001.*
FDA Label Image

Figure-03 (Figure 03)

Figure-03 (Figure 03)
A line graph showing the percentage of subjects experiencing a major cardiovascular event over time in years, comparing atorvastatin 10 mg and atorvastatin 80 mg. The horizontal axis represents time to first major cardiovascular endpoint up to 5 years, and the vertical axis shows the percentage of subjects experiencing the event. A hazard ratio (HR) of 0.78 with confidence interval and p-value is noted.*
FDA Label Image

10mg Carton Label (2c013703 Cd5c 4d37 8180 0a0615925ae4 01)

10mg Carton Label (2c013703 Cd5c 4d37 8180 0a0615925ae4 01)
Packaging label of Major Pharmaceuticals Atorvastatin Calcium 10 mg film-coated tablets, USP, oral dosage form. The label indicates a unit dose package containing 100 tablets (10 x 10), with instructions for pharmacists to dispense with a patient information leaflet. The label includes storage instructions, a note on dosage information, and states Rx only. Packaged and distributed by Major Pharmaceuticals, Indianapolis, IN.*
FDA Label Image

20mg Carton Label (2c013703 Cd5c 4d37 8180 0a0615925ae4 00)

20mg Carton Label (2c013703 Cd5c 4d37 8180 0a0615925ae4 00)
Atorvastatin Calcium 20 mg film-coated tablets unit dose packaging label by Major Pharmaceuticals. The label includes the NDC 0904-6291-61 and states 100 tablets (10 x 10) with instructions for dispensing with a patient information leaflet. It provides storage instructions and a caution that the unit dose package is not child resistant, intended for institutional use only. The label features Major Pharmaceuticals branding and a barcode at the bottom.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.